Skip to content

Study on the rule and mechanism of treating functional gastrointestinal diseases from the perspective of liver and spleen

Study on the rule and mechanism of treating functional gastrointestinal diseases from the perspective of liver and spleen

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003417
Enrollment
Unknown
Registered
2020-06-21
Start date
2020-06-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional gastroenteropathy

Interventions

Sponsors

China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers without abnormal clinical manifestations; 2. Patients who meet nerd's syndrome of disharmony of liver and stomach and IBS-D syndrome of liver depression and spleen deficiency; 3. Patients between 18-70 years old; 4. Probiotics such as antibiotics, steroids, Chinese herbal medicine preparations (including oral and intravenous), microecological preparations or yoghurt, etc. taken in the past week; 5. The subjects were informed and signed the informed consent voluntarily; 6. Patients with certain reading ability.

Exclusion criteria

Exclusion criteria: 1. Patients with serious heart, liver, kidney and other major organ diseases, hematopoietic system, nervous system or mental diseases; 2. Patients with other organic diseases of the digestive system (such as peptic ulcer) or systemic diseases (such as hyperthyroidism and diabetes) that affect the gastrointestinal motility; 3. Patients who are using or need to use drugs that may affect gastrointestinal function (antidiarrheal, antidepressant, antianxiety, intestinal flora regulator, antibiotics, etc.); 4. Patients who have a history of drug allergy and a history of severe food allergy; 5. Patients with metal medical devices implanted in the body; 6. Patients with pregnancy plan within three months.

Design outcomes

Primary

MeasureTime frame
IBS - SSS scale;7 point Likert scale;

Secondary

MeasureTime frame
Hamilton anxiety scale;IBS - QOL scale;Overall Impression scale;TCM Syndrome Score Scale;Hamilton depression scale;Symptoms integral scale;SF - 36 scale;

Countries

China

Contacts

Public ContactTang Xudong

China Academy of Chinese Medical Sciences

txdly@sina.com.cn+86 10-62835001

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026